China Pharma Holdings, Inc. CPHI

0.75 0.01 1.35% as of 25 Sep
Market cap
$31.8M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
1.25 0.89 0.29 0.58 2.30 1.81 0.96 0.92 0.56 0.70
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.16
P/Operating CF
34.16 13.44 (91.05) 8.09 (111.82) 58.60 (473.48) 12.96 7.91 7.39
P/B ratio
0.23 0.52 0.27 1.10 3.68 2.45 1.13 0.38 0.17 0.19
EV/Sales
1.97 1.28 0.43 1.22 2.78 2.19 1.24 1.25 1.05 1.11
EV/EBITDA
0.00 0.00 1,657.33 0.00 56.11 235.91 0.00 0.00 0.00 0.00
EV/FCF
(184.67) (2.47) (1.13) (3.60) (11.21) (8.39) (9.27) (151.42) (11.28) 22.38
Current Ratio
0.32 0.65 0.88 0.47 0.86 0.47 0.56 0.87 1.33 1.69
Net Debt/EBITDA
(0.98) (0.92) 529.33 (0.47) 9.70 41.80 (0.18) (0.57) (0.42) (1.25)
Debt/Equity
0.09 0.31 0.33 0.57 1.59 0.65 0.47 0.22 0.21 0.17
ROE
(20.91%) (62.31%) (52.43%) (77.08%) (48.49%) (33.25%) (104.99%) (29.34%) (37.81%) (13.96%)
ROA
(13.89%) (30.21%) (17.98%) (19.65%) (15.53%) (13.23%) (61.24%) (20.41%) (27.84%) (10.49%)
ROIC
(8.31%) (30.16%) (20.46%) (47.32%) (16.79%) (13.17%) (103.64%) (19.06%) (23.58%) (7.81%)
Return on Tangible Assets
481.51% (151.01%) (49.05%) (124.22%) (28.66%) (30.23%) (174.74%) (59.76%) (72.46%) (28.62%)
Average Days of Receivables
25.60 21.15 34.48 20.30 28.16 17.79 22.79 32.18 67.85 99.02
Earnings Yield
(61.98%) (117.39%) (145.03%) (83.94%) (16.67%) (14.41%) (200.00%) (91.05%) (258.82%) (88.00%)
Free Cash Flow Yield
(0.85%) (58.18%) (130.22%) (58.02%) (10.78%) (14.49%) (13.96%) (0.90%) (16.57%) 7.06%
Free Cash Flow per Share
0.00 (0.40) (2.10) (7.72) (7.45) (10.43) 5.42 21.00 8.08 30.99
Book value per Share
5.30 4.44 22.03 40.82 65.20 91.79 105.94 346.32 493.94 675.56
Free Cash Flow
0.01 (0.70) (0.71) (0.81) (0.69) (0.91) 0.47 1.83 0.70 2.70
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates